| LDR | | 01833casuu2200481 a 4500 |
| 001 | | 000013309611 |
| 005 | | 20070906150639 |
| 008 | | 911113c19929999nyumrzp 0 a0eng d |
| 010 | |
▼a sn 91003051 |
| 022 | 0 |
▼a 0965-0407 |
| 030 | |
▼a ONREE8 |
| 035 | |
▼a (KERIS)REF000007127312 |
| 037 | |
▼b Cognizant Communication Corp., 3 Hartsdale Rd., Elmsford, NY 10523 |
| 040 | |
▼a NSDP
▼c NSDP
▼d DNLM
▼d WaU
▼d NST
▼d OUCA
▼d MH
▼d HkUST
▼d OCoLC
▼d OUCA
▼d GU
▼d NSDP
▼d 224010 |
| 042 | |
▼a nsdp
▼a lcd |
| 050 | 14 |
▼a RC261.A1
▼b O53 |
| 060 | 00 |
▼a W1
▼b ON107P |
| 082 | 10 |
▼a 616.99
▼2 12 |
| 090 | |
▼a 616.99
▼b O58co |
| 210 | 0 |
▼a Oncol. res. |
| 222 | 0 |
▼a Oncology research |
| 245 | 00 |
▼a Oncology research. |
| 246 | 13 |
▼a Oncology research incorporating anti-cancer drug design,
▼f 2002- |
| 246 | 17 |
▼a Oncology research/Anti-cancer drug design
▼f 2002- |
| 260 | |
▼a New York:
▼b Pergamon Press,
▼c c1992-. |
| 300 | |
▼a v.:
▼b ill.;
▼c 28 cm. |
| 310 | |
▼a Monthly |
| 362 | 0 |
▼a Vol. 4, no. 1- |
| 500 | |
▼a Published: Elmsford, NY : Cognizant Communication Corp., <2003-> |
| 500 | |
▼a Latest issue consulted: Vol. 14, no. 3 (2003). |
| 510 | 2 |
▼a Chemical abstracts
▼x 0009-2258
▼b 1992- |
| 515 | |
▼a Some issues combined. |
| 530 | |
▼a Issued also online. |
| 580 | |
▼a Absorbed: Anti-cancer drug design. |
| 650 | 0 |
▼a Cancer
▼v Periodicals. |
| 650 | 0 |
▼a Oncology
▼v Periodicals. |
| 650 | 2 |
▼a Medical Oncology
▼v Periodicals. |
| 650 | 2 |
▼a Neoplasms
▼v Periodicals. |
| 650 | 2 |
▼a Research
▼v Periodicals. |
| 776 | 1 |
▼t Oncology research (Online)
▼x 1555-3906
▼w (DLC) 2005212309
▼w (OCoLC)39097969 |
| 780 | 00 |
▼t Cancer communications
▼x 0955-3541
▼w (DLC) 89642492
▼w (OCoLC)20287284 |
| 780 | 15 |
▼t Anti-cancer drug design
▼x 0266-9536
▼g 2002
▼w (DLC)sn 86017056
▼w (OCoLC)12929721 |